R. 1. Muñoz, L. Lauber, K. Schiller, M. Manfredi, A. Herrmann et al., The role of defective clearance of apoptotic cells in systemic autoimmunity, Nature Reviews Rheumatology, vol.42, issue.5, pp.280-289, 2010.
DOI : 10.4049/jimmunol.166.7.4498

M. Kuraya, Z. Ming, X. Liu, M. Matsushita, and T. Fujita, Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation, Immunobiology, vol.209, issue.9, pp.689-97, 2005.
DOI : 10.1016/j.imbio.2004.11.001

L. Munthe-fog, T. Hummelshøj, B. Hansen, C. Koch, H. Madsen et al., The Impact of FCN2 Polymorphisms and Haplotypes on the Ficolin-2 Serum Levels, Scandinavian Journal of Immunology, vol.19, issue.4, pp.383-92, 2007.
DOI : 10.1074/jbc.M310555200

H. Watanabe, R. Saito, T. Asano, S. Sato, H. Iwadate et al., Serum L-ficolin levels in patients with systemic lupus erythematosus, Modern Rheumatology, vol.17, issue.6, pp.899-902, 2012.
DOI : 10.3899/jrheum.080361

N. Tanha, K. Pilely, M. Faurschou, P. Garred, and S. Jacobsen, Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus, Clinical Rheumatology, vol.62, issue.6, pp.335-341, 2017.
DOI : 10.1002/acr.20116

E. Hein, J. Bay, L. Munthe-fog, and P. Garred, Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures, Molecular Immunology, vol.56, issue.4, pp.406-418, 2013.
DOI : 10.1016/j.molimm.2013.05.233

A. Trouw and M. Daha, Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis, Expert Opinion on Biological Therapy, vol.29, issue.2, pp.243-51, 2005.
DOI : 10.1006/clim.1998.4620

R. Takahashi, A. Tsutsumi, K. Ohtani, D. Goto, I. Matsumoto et al., Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus, Clinical and Experimental Immunology, vol.79, issue.100
DOI : 10.1182/blood-2002-04-1033

S. Soliman and C. Mohan, Lupus nephritis biomarkers, Clinical Immunology, vol.185, 2016.
DOI : 10.1016/j.clim.2016.08.001

R. Nisihara, F. Magrini, V. Mocelin, and I. Messias-reason, Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients, Human Immunology, vol.74, issue.8, pp.907-917, 2013.
DOI : 10.1016/j.humimm.2013.04.030

L. Arnaud, J. Fagot, A. Mathian, M. Paita, A. Fagot-campagna et al., Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study, Autoimmunity Reviews, vol.13, issue.11, pp.1082-1091, 2014.
DOI : 10.1016/j.autrev.2014.08.034

M. Tektonidou, A. Dasgupta, and M. Ward, Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis, Arthritis & Rheumatology, vol.35, issue.Suppl 2, pp.1432-1473, 1971.
DOI : 10.3899/jrheum.080214

D. Yap, C. Tang, M. Ma, M. Lam, and T. Chan, Survival analysis and causes of mortality in patients with lupus nephritis, Nephrology Dialysis Transplantation, vol.27, issue.8
DOI : 10.1093/ndt/gfs073

R. Cervera, M. Khamashta, J. Font, G. Sebastiani, A. Gil et al., Systemic Lupus Erythematosus, Medicine, vol.72, issue.2, pp.113-137, 1993.
DOI : 10.1097/00005792-199303000-00005

URL : https://hal.archives-ouvertes.fr/hal-01563359

F. Yu, M. Haas, R. Glassock, and M. Zhao, Redefining lupus nephritis: clinical implications of pathophysiologic subtypes, Nature Reviews Nephrology, vol.65, issue.8, pp.483-95, 2017.
DOI : 10.1111/j.1523-1755.2004.00443.x

K. Davies, A. Peters, H. Beynon, and M. Walport, Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies., Journal of Clinical Investigation, vol.90, issue.5, pp.2075-83, 1992.
DOI : 10.1172/JCI116090

R. Saxena, T. Mahajan, and C. Mohan, Lupus nephritis: current update, Arthritis Research & Therapy, vol.13, issue.5, p.240, 2011.
DOI : 10.1191/0961203304lu525oa

URL : https://doi.org/10.1186/ar3378

S. Bernatsky, J. Boivin, L. Joseph, S. Manzi, E. Ginzler et al., Mortality in systemic lupus erythematosus, Arthritis & Rheumatism, vol.51, issue.8, pp.2550-2557, 2006.
DOI : 10.1093/oxfordjournals.aje.a009122

R. Kewalramani and A. Singh, Immunopathogenesis of lupus and lupus nephritis: recent insights, Current Opinion in Nephrology and Hypertension, vol.11, issue.3, pp.273-280, 2002.
DOI : 10.1097/00041552-200205000-00002

L. Watson, V. Leone, C. Pilkington, K. Tullus, S. Rangaraj et al., Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort, Arthritis & Rheumatism, vol.30, issue.7, pp.2356-65, 2012.
DOI : 10.1056/NEJMoa043731

. Systémique-en-tunisie, Systemic lupus erythematosus in Tunisia. A multicentric study About 295 cases], 768?74. 14. Satirapoj B, 2003.

S. Lapkittichareonchai, Predictors of renal involvement in patients with systemic lupus erythematosus The significance of arterial hypertension at the onset of clinical lupus nephritis, 17?25. 15. Naiker IP, pp.230-233, 1997.

Q. Zhang, L. Sun, and J. L. , Spot urine protein/creatinine ratio is unreliable estimate of 24???h proteinuria in lupus nephritis when the histological scores of activity index are higher, Lupus, vol.12, issue.9, pp.943-950, 2015.
DOI : 10.5414/CN107094

J. Cameron, Z. Lupus-nephritis-touma, M. Urowitz, D. Ibañez, and D. Gladman, Disponible sur: http://www.rhumatologie.asso.fr/05-Bibliotheque/Publications/pub-72-162-167.asp 19 Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment, 413?24. 18. Rein et lupus : données récentes [Internet]. [cité 18 nov 2017, pp.688-97, 1999.

J. Ishizaki, K. Saito, M. Nawata, Y. Mizuno, M. Tokunaga et al., Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus, Rheumatology, vol.54, issue.3, pp.405-417, 2015.
DOI : 10.1093/rheumatology/keu343

S. Almaani, A. Meara, and B. Rovin, Update on Lupus Nephritis, Clinical Journal of the American Society of Nephrology, vol.12, issue.5, pp.825-860, 2017.
DOI : 10.2215/CJN.05780616

A. Macedo, L. Isaac, A. Bengtsson, and G. Sturfelt, Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway Complement deficiencies and systemic lupus erythematosus, Front Immunol. Autoimmunity. déc, vol.740, issue.8, pp.560-566, 2007.

S. Nasiri, M. Karimifar, Z. Bonakdar, and M. Salesi, RETRACTED ARTICLE: Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic, Rheumatology International, vol.18, issue.12, pp.1605-1614, 2010.
DOI : 10.1007/s100670050045

E. Smith, A. Jorgensen, M. Beresford, U. Jsle-study, and . Group, Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus, Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study, pp.160879-160906, 2016.

J. Gozdowska and T. Korcz, The importance of serological and histopathological diagnosis of the different forms of systemic lupus erythematosus with and without lupus nephritis, 1212?7. 28. Malgorzata Wislowska, 2014.

G. Moroni, S. Quaglini, A. Radice, B. Trezzi, F. Raffiotta et al., The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy, Journal of Immunology Research, vol.110, issue.4
DOI : 10.3389/fimmu.2013.00117

S. Hsieh, C. Tsai, C. Yu, F. Irshaid, H. Nagaraja et al., Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems The complex nature of serum C3 and C4 as biomarkers of lupus renal flare, Open Access Rheumatol Res Rev. Lupus. oct, vol.819, issue.11, pp.1272-80, 2010.

G. Moroni, A. Radice, G. Giammarresi, S. Quaglini, B. Gallelli et al., Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis):234?7. 33. Welch TR. The complement system in renal diseases, Ann Rheum Dis. févr Nephron. juill, vol.6888, issue.34, 1982.

D. Solomon, American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests, 1271?7. 35. Kavanaugh AF, pp.546-55, 1982.

O. Rekvig, The anti-DNA antibody: origin and impact, dogmas and controversies, Nature Reviews Rheumatology, vol.157, issue.9
DOI : 10.1007/s00281-014-0428-6

C. Ravirajan, L. Rowse, J. Macgowan, D. Isenberg, J. Hu et al., An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus, Rheumatol Oxf Engl. déc Arthritis Rheum. avr, vol.4052, issue.124, pp.1129-1166, 2001.

J. Balow, Clinical presentation and monitoring of lupus nephritis, Lupus, vol.9, issue.1, pp.25-30, 2005.
DOI : 10.1191/096120300678828424

M. Mannik, C. Merrill, L. Stamps, M. Wener, and M. Daha, Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis, J Rheumatol. juill Mol Immunol. janv, vol.3044, issue.71?3, pp.133-141, 2003.

L. Watson and M. Beresford, Urine biomarkers in juvenile-onset SLE nephritis, Pediatric Nephrology, vol.48, issue.Suppl 10, pp.363-74, 2013.
DOI : 10.1002/art.34426

J. Esdaile, M. Abrahamowicz, L. Joseph, T. Mackenzie, Y. Li et al., Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus Why some tests fail Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus, Arthritis Rheum. mars Arthritis Rheum. oct, vol.3944, issue.4410, pp.2342-2351, 1996.

G. Bertsias, M. Tektonidou, Z. Amoura, M. Aringer, I. Bajema et al., Joint European League Against Rheumatism and European Renal Association???European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis, American College of Rheumatology guidelines for screening1771?82. 48. Parikh SV, pp.797-808, 2012.
DOI : 10.1136/annrheumdis-2012-201940

. Past, F. Present, B. Rovin, S. Parikh, A. Alvarado et al., The kidney biopsy in lupus nephritis: is it still relevant? Rheum Dis Clin North Am The classification of glomerulonephritis in systemic lupus erythematosus revisited, 241?50. 51. Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis, p.250, 2004.

H. Austin, G. Illei, M. Braun, J. Balow, D. Fraser et al., Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions, J Am Soc Nephrol JASN. avr Mol Immunol. janv, vol.2044, issue.41?3, pp.33-43, 2007.

J. Rosain, S. Ngo, P. Bordereau, N. Poulain, S. Roncelin et al., Déficits en protéines du complément et pathologies humaines 1 mai 2014, 271?80. 55. Basiglio CL

M. Immunol-baltim, 15 nov, pp.6096-104, 1950.

Y. Ma, M. Cho, M. Zhao, J. Park, M. Matsushita et al., Human mannosebinding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement, 25307?12. 58. Dragon-Durey M-A. Le système du Complément [Internet], p.2011, 2004.

T. Hummelshoj, L. Fog, H. Madsen, R. Sim, and P. Garred, Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen), Molecular Immunology, vol.45, issue.6, pp.1623-1655, 2008.
DOI : 10.1016/j.molimm.2007.10.006

Y. Yae, S. Inaba, H. Sato, K. Okochi, F. Tokunaga et al., Isolation and characterization of a thermolabile ??-2 macroglycoprotein (???thermolabile substance??? or ???Hakata antigen???) detected by precipitating (auto) antibody in sera of patients with systemic lupus erythematosus, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol.1078, issue.3, pp.369-76, 1991.
DOI : 10.1016/0167-4838(91)90158-V

M. Akaiwa, Y. Yae, R. Sugimoto, S. Suzuki, T. Iwaki et al., Hakata Antigen, a New Member of the Ficolin/Opsonin p35 Family, Is a Novel Human Lectin Secreted into Bronchus/Alveolus and Bile, Journal of Histochemistry & Cytochemistry, vol.89, issue.6, pp.777-86, 1999.
DOI : 10.1172/JCI115554

D. Kilpatrick, T. Fujita, and M. Matsushita, P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients, Immunology Letters, vol.67, issue.2
DOI : 10.1016/S0165-2478(98)00147-3

M. Matsushita, Y. Endo, S. Taira, Y. Sato, T. Fujita et al., A Novel Human Serum Lectin with Collagen- and Fibrinogen-like Domains That Functions as an Opsonin, Journal of Biological Chemistry, vol.271, issue.5, pp.2448-54, 1996.
DOI : 10.1074/jbc.271.5.2448

J. Lu, P. Tay, O. Kon, and K. K. Reid, Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9, Biochemical Journal, vol.313, issue.2, 1996.
DOI : 10.1042/bj3130473

D. Kilpatrick and J. Chalmers, Human L-Ficolin (Ficolin-2) and Its Clinical Significance, Journal of Biomedicine and Biotechnology, vol.66, issue.236
DOI : 10.1016/j.molimm.2006.07.151

URL : http://doi.org/10.1155/2012/138797

L. Munthe-fog, T. Hummelshøj, B. Hansen, C. Koch, H. Madsen et al., The Impact of FCN2 Polymorphisms and Haplotypes on the Ficolin-2 Serum Levels, Scandinavian Journal of Immunology, vol.19, issue.4, pp.383-92, 2007.
DOI : 10.1074/jbc.M310555200

M. Matsushita, Ficolins in complement activation, Molecular Immunology, vol.55, issue.1, pp.22-28, 2013.
DOI : 10.1016/j.molimm.2012.08.017

S. Roscher, T. Hartung, S. Morath, M. Matsushita, and D. Maennel, Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in Hficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement, J Immunol Baltim Md J Immunol Baltim Md, vol.182172, issue.152, pp.1198-202, 1950.

X. Zhang and M. Ali, Ficolins: Structure, Function and Associated Diseases, Adv Exp
DOI : 10.1007/978-0-387-78952-1_9

Y. Endo, M. Matsushita, and T. Fujita, New Insights into the Role of??Ficolins in the Lectin Pathway of Innate Immunity, Int Rev Cell Mol Biol, vol.316, pp.49-110, 2015.
DOI : 10.1016/bs.ircmb.2015.01.003

J. Liu, M. Ali, Y. Shi, Y. Zhao, F. Luo et al., Specifically Binding of L-ficolin to N-glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation, Cellular & Molecular Immunology, vol.6, issue.4, pp.235-279, 2009.
DOI : 10.1038/cmi.2009.32

Z. Ming, X. Liu, M. Matsushita, and T. Fujita, Specific binding of L-ficolin and Hficolin to apoptotic cells leads to complement activation, recognizes DNA and participates in the clearance of dying host cells856?65. 76. Kuraya M, 2005.

H. Watanabe, R. Saito, T. Asano, S. Sato, H. Iwadate et al., Serum L-ficolin levels in patients with systemic lupus erythematosus Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus, 335?41. 80. Nisihara RM, Magrini F, Mocelin V, Messias-Reason IJ. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients, pp.907-917, 2012.

J. Schifferli, G. Steiger, G. Hauptmann, P. Spaeth, A. Sjöholm et al., Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus, 1427?38. 88. Waxman FJ, 1982.

K. Gavit and S. Mccarty, Complement depletion accelerates the clearance of immune complexes from the circulation of primates, J Clin Invest. oct, vol.74, issue.4, 1984.

X. Howard, A. Maiti, J. Anaya, G. Bruner, E. Brown et al., ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus, Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare141?9. 93. Tanha N, Troelsen L, From Hermansen M, 1988.

S. Saevarsdottir, K. Steinsson, B. Ludviksson, G. Grondal, H. Valdimarsson et al., Mannanbinding lectin may facilitate the clearance of circulating immune complexes--implications from a study on C2-deficient individuals Tolerance and autoimmunity Lupus Nephritis: An Overview of Recent Findings al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, MBL2 gene variants coding for mannose-binding lectin deficiency are associated with increased risk of nephritis in Danish patients with systemic lupus erythematosus, pp.781-95, 2001.

M. Stegert, M. Bock, and M. Trendelenburg, Clinical presentation of human C1q deficiency

Y. Wang, Q. Hu, J. Madri, S. Rollins, A. Chodera et al., Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5., Proceedings of the National Academy of Sciences, vol.93, issue.16, pp.8563-8571, 1996.
DOI : 10.1073/pnas.93.16.8563

N. Sato, I. Ohsawa, S. Nagamachi, M. Ishii, G. Kusaba et al., Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis, Lupus, vol.3, issue.13, pp.1378-86, 2011.
DOI : 10.1016/S0960-9822(03)00575-X

H. Watanabe, G. Garnier, A. Circolo, R. Wetsel, P. Ruiz et al., Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B, The Journal of Immunology, vol.164, issue.2, pp.786-94, 1950.
DOI : 10.4049/jimmunol.164.2.786

M. Elliott, T. Jarmi, P. Ruiz, Y. Xu, V. Holers et al., Effects of complement factor D deficiency on the renal disease of MRL/lpr mice, Kidney International, vol.65, issue.1, pp.129-167, 2004.
DOI : 10.1111/j.1523-1755.2004.00371.x

L. Bao, M. Haas, and R. Quigg, Complement Factor H Deficiency Accelerates Development of Lupus Nephritis, Journal of the American Society of Nephrology, vol.22, issue.2, pp.285-95, 2011.
DOI : 10.1681/ASN.2010060647

H. Sekine, T. Kinser, F. Qiao, E. Martinez, E. Paulling et al., The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice, Arthritis & Rheumatism, vol.137, issue.4, pp.1076-85, 2011.
DOI : 10.1111/j.1365-2249.2004.02525.x

D. Birmingham and L. Hebert, The Complement System in Lupus Nephritis, Seminars in Nephrology, vol.35, issue.5, pp.444-54, 2015.
DOI : 10.1016/j.semnephrol.2015.08.006

D. Santer, A. Wiedeman, T. Teal, P. Ghosh, and K. Elkon, Plasmacytoid Dendritic Cells and C1q Differentially Regulate Inflammatory Gene Induction by Lupus Immune Complexes, The Journal of Immunology, vol.188, issue.2
DOI : 10.4049/jimmunol.1102797

URL : http://www.jimmunol.org/content/jimmunol/188/2/902.full.pdf

M. Immunol-baltim, 15 janv 2012, pp.902-917, 1950.

M. Son, F. Santiago-schwarz, Y. Al-abed, and D. B. , C1q limits dendritic cell differentiation and activation by engaging LAIR-1, Proceedings of the National Academy of Sciences, vol.28, issue.7, pp.3160-3167, 2012.
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T

URL : http://www.pnas.org/content/109/46/E3160.full.pdf

C. Lood, B. Gullstrand, L. Truedsson, A. Olin, G. Alm et al., C1q inhibits immune complex-induced interferon-?? production in plasmacytoid dendritic cells: A novel link between C1q deficiency and systemic lupus erythematosus pathogenesis, Arthritis & Rheumatism, vol.156, issue.10, pp.3081-90, 2009.
DOI : 10.4049/jimmunol.168.10.5222

O. Chan, L. Hannum, A. Haberman, M. Madaio, and M. Shlomchik, A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus, The Journal of Experimental Medicine, vol.161, issue.10, pp.1639-1687, 1999.
DOI : 10.1084/jem.184.5.2049

N. Jacob and W. Stohl, Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: Past, present, and future, Autoimmunity, vol.45, issue.2, pp.84-97, 2010.
DOI : 10.1016/j.molimm.2008.06.027

J. Leffler, B. Gullstrand, A. Jönsen, J. Nilsson, M. Martin et al., Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus, Arthritis Research & Therapy, vol.15, issue.4, p.84, 2013.
DOI : 10.1046/j.1365-2249.1996.d01-839.x

C. Farrera and B. Fadeel, Macrophage clearance of neutrophil extracellular traps is a silent 98 process, J Immunol Baltim Md, vol.191, issue.5, pp.2647-56, 1950.

J. Leffler, M. Martin, B. Gullstrand, H. Tydén, C. Lood et al., Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease, The Journal of Immunology, vol.188, issue.7, pp.3522-3553, 1950.
DOI : 10.4049/jimmunol.1102404

N. Jourde-chiche, L. Daniel, L. Chiche, S. Burtey, J. Mancini et al., Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis, Clinical Nephrology, vol.77, issue.03, pp.211-219, 2012.
DOI : 10.5414/CN107274

V. Agnello, D. Koffler, J. Eisenberg, R. Winchester, and H. Kundel, C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types, J Exp Med. 1 sept, vol.134, issue.3 2, pp.228-241, 1971.

V. Agnello, R. Winchester, and H. Kunkel, Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion

C. Siegert, M. Daha, M. Westedt, E. Van-der-voort, and F. Breedveld, IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus, J Rheumatol. févr, vol.18, issue.2, pp.230-234, 1991.
DOI : 10.1136/ard.52.12.851

URL : http://ard.bmj.com/content/annrheumdis/52/12/851.full.pdf

P. Norsworthy and K. Davies, Complement Components and Their Autoantibodies, Molecular Biotechnology, vol.23, issue.3, pp.259-70, 2003.
DOI : 10.1385/MB:23:3:259

A. Jesus, C. Silva, M. Carneiro-sampaio, M. Sheinberg, C. Mangueira et al., Anti-C1q Antibodies in Juvenile-Onset Systemic Lupus Erythematosus, Annals of the New York Academy of Sciences, vol.15, issue.Suppl 1, pp.235-243, 2009.
DOI : 10.1111/j.1749-6632.2009.04675.x

Y. Yin, X. Wu, G. Shan, and X. Zhang, Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis, Lupus, vol.19, issue.10, pp.1088-97, 2012.
DOI : 10.1186/1471-2288-11-41

M. Trendelenburg, Anti-C1q antibodies as a diagnostic marker of proliferative lupus nephritis: Comment on the article by Katsumata et al, Arthritis & Rheumatism, vol.64, issue.1, pp.324-325, 2012.
DOI : 10.1002/art.33384

Y. Pang, Y. Tan, Y. Li, J. Zhang, Y. Guo et al., Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis, Kidney International, vol.90, issue.6, pp.1357-67, 2016.
DOI : 10.1016/j.kint.2016.08.010

C. Siegert, M. Daha, C. Tseng, I. Coremans, L. Van-es et al., Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus., Annals of the Rheumatic Diseases, vol.52, issue.12, pp.851-857, 1993.
DOI : 10.1136/ard.52.12.851

V. Frémeaux-bacchi, L. Noël, and J. Schifferli, No lupus nephritis in the absence of antiC1q autoantibodies? Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren

M. Trendelenburg, J. Marfurt, I. Gerber, A. Tyndall, and J. Schifferli, Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients, Arthritis & Rheumatism, vol.36, issue.1, pp.187-195, 1999.
DOI : 10.1093/rheumatology/36.1.32

A. Matrat, C. Veysseyre-balter, P. Trolliet, E. Villar, F. Dijoud et al., Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares, Lupus, vol.114, issue.1, pp.28-34, 2011.
DOI : 10.1172/JCI200422820

X. Yang, Y. Tan, F. Yu, and M. Zhao, Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis, Nephrology Dialysis Transplantation, vol.27, issue.9, pp.3552-3561, 2012.
DOI : 10.1093/ndt/gfs179

E. Akhter, R. Burlingame, A. Seaman, L. Magder, and M. Petri, Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers, Lupus, vol.35, issue.12, pp.1267-74, 2011.
DOI : 10.1191/096120398678920172

M. Mannik and M. Wener, Deposition of antibodies to the collagen-like region of C1Q in renal glomeruli of patients with proliferative lupus glomerulonephritis, Arthritis & Rheumatism, vol.24, issue.8, pp.1504-1515, 1997.
DOI : 10.1042/bj1550005

Y. Pang, X. Yang, Y. Song, F. Yu, and M. Zhao, Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro, Immunobiology, vol.219, issue.12, pp.980-989, 2014.
DOI : 10.1016/j.imbio.2014.07.004

S. Thanei and M. Trendelenburg, Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages, The Journal of Immunology, vol.56, issue.10, pp.2063-74, 1950.
DOI : 10.1002/art.22947

D. Birmingham, J. Bitter, E. Ndukwe, S. Dials, T. Gullo et al., Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare, Clinical Journal of the American Society of Nephrology, vol.11, issue.1, pp.47-53, 2016.
DOI : 10.2215/CJN.03990415

K. Kenyon, C. Cole, F. Crawford, J. Kappler, J. Thurman et al., IgG Autoantibodies against Deposited C3 Inhibit Macrophage-Mediated Apoptotic Cell Engulfment in Systemic Autoimmunity, The Journal of Immunology, vol.187, issue.5, pp.2101-2112, 1950.
DOI : 10.4049/jimmunol.1003468

S. Yoshizawa, K. Nagasawa, Y. Yae, Y. Niho, and K. Okochi, A thermolabile ??2-macroglycoprotein (TMG) and the antibody against TMG in patients with systemic lupus erythematosus, Clinica Chimica Acta, vol.264, issue.2, pp.219-244, 1997.
DOI : 10.1016/S0009-8981(97)00078-8

J. Wilson, R. Jack, W. Wong, P. Schur, and D. Fearon, Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus., Journal of Clinical Investigation, vol.76, issue.1, pp.182-90, 1985.
DOI : 10.1172/JCI111944

J. Cook, M. Kazatchkine, P. Bourgeois, F. Mignon, J. Mery et al., Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus, Clinical Immunology and Immunopathology, vol.38, issue.1, pp.135-143, 1986.
DOI : 10.1016/0090-1229(86)90131-5

A. Mir and B. Balsalobre, Inhibition of complement-dependent phagocytosis by 101

M. Seelen, L. Trouw, J. Van-der-hoorn, F. Fallaux-van-den-houten, T. Huizinga et al., Autoantibodies against mannose-binding lectin in systemic lupus erythematosus, Clinical and Experimental Immunology, vol.152, issue.2, pp.335-378, 2003.
DOI : 10.1084/jem.194.6.781

R. Takahashi, A. Tsutsumi, K. Ohtani, D. Goto, I. Matsumoto et al., Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus, Clinical and Experimental Immunology, vol.79, issue.100
DOI : 10.1182/blood-2002-04-1033

V. Pradhan, G. Mahant, A. Rajadhyaksha, P. Surve, V. Rajendran et al., A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients, Rheumatology International, vol.32, issue.2, pp.1193-1202, 2013.
DOI : 10.2174/157339709787315384

L. Muñoz, K. Lauber, M. Schiller, A. Manfredi, and M. Herrmann, The role of defective clearance of apoptotic cells in systemic autoimmunity, Nature Reviews Rheumatology, vol.42, issue.5, pp.280-289, 2010.
DOI : 10.4049/jimmunol.166.7.4498

M. Kuraya, Z. Ming, X. Liu, M. Matsushita, and T. Fujita, Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation, Immunobiology, vol.209, issue.9, pp.689-97, 2005.
DOI : 10.1016/j.imbio.2004.11.001

L. Munthe-fog, T. Hummelshøj, B. Hansen, C. Koch, H. Madsen et al., The Impact of FCN2 Polymorphisms and Haplotypes on the Ficolin-2 Serum Levels, Scandinavian Journal of Immunology, vol.19, issue.4, pp.383-92, 2007.
DOI : 10.1074/jbc.M310555200

H. Watanabe, R. Saito, T. Asano, S. Sato, H. Iwadate et al., Serum L-ficolin levels in patients with systemic lupus erythematosus, Modern Rheumatology, vol.17, issue.6, pp.899-902, 2012.
DOI : 10.3899/jrheum.080361

N. Tanha, K. Pilely, M. Faurschou, P. Garred, and S. Jacobsen, Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus, Clinical Rheumatology, vol.62, issue.6, 2016.
DOI : 10.1002/acr.20116

E. Hein, J. Bay, L. Munthe-fog, and P. Garred, Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures, Molecular Immunology, vol.56, issue.4, pp.406-418, 2013.
DOI : 10.1016/j.molimm.2013.05.233

C. Addobbati, J. De-azevêdo-silva, N. Tavares, O. Monticielo, R. Xavier et al., Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis, Annals of Human Genetics, vol.140, issue.1, pp.1-6, 2016.
DOI : 10.1016/j.cell.2010.03.003

A. Jesus, C. Silva, M. Carneiro-sampaio, M. Sheinberg, C. Mangueira et al., Anti-C1q Antibodies in Juvenile-Onset Systemic Lupus Erythematosus, Annals of the New York Academy of Sciences, vol.15, issue.Suppl 1, pp.235-243, 2009.
DOI : 10.1111/j.1749-6632.2009.04675.x

R. Takahashi, A. Tsutsumi, K. Ohtani, D. Goto, I. Matsumoto et al., Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus, Clinical and Experimental Immunology, vol.79, issue.100
DOI : 10.1182/blood-2002-04-1033

S. Soliman and C. Mohan, Lupus nephritis biomarkers, Clinical Immunology, vol.185, 2016.
DOI : 10.1016/j.clim.2016.08.001

R. Nisihara, F. Magrini, V. Mocelin, and I. Messias-reason, Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients, Human Immunology, vol.74, issue.8, pp.907-917, 2013.
DOI : 10.1016/j.humimm.2013.04.030

A. Brady, B. Spencer, A. Falsey, and M. Nahm, Blood Collection Tubes Influence Serum Ficolin-1 and Ficolin-2 Levels, Clinical and Vaccine Immunology, vol.21, issue.1, pp.51-56, 2014.
DOI : 10.1128/CVI.00607-13

URL : http://cvi.asm.org/content/21/1/51.full.pdf

E. Hein, J. Bay, L. Munthe-fog, and P. Garred, Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures, Molecular Immunology, vol.56, issue.4, pp.406-418, 2013.
DOI : 10.1016/j.molimm.2013.05.233

C. Bombardier, D. Gladman, M. Urowitz, D. Caron, and C. Chang, Derivation of the sledai. A disease activity index for lupus patients, Arthritis & Rheumatism, vol.19, issue.6, pp.630-670, 1992.
DOI : 10.1002/art.1780350606